Immunotherapy for Hepatocellular Carcinoma: A 2021 Update

Immunotherapy for Hepatocellular Carcinoma: A 2021 Update

Hepatocellular carcinoma (HCC) is one of one of the most frequent liver cancers and the fourth leading cause of cancer-related mortality worldwide. Current treatment options such as surgery, neoadjuvant chemoradiotherapy, liver transplantation, and radiofrequency ablation will benefit only a very sm...

Full description

Bibliographic Details
Main Authors: Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Michail Vailas, Dimitrios Moris, Efthymios Gkotsis, Stylianos Kykalos, Michalis V. Karamouzis, Dimitrios Schizas
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
hepatocellular carcinoma
immunotherapy
immune checkpoint inhibitors
cancer vaccines
adoptive cellular immunotherapy
oncolytic viruses
Online Access:https://www.mdpi.com/2072-6694/12/10/2859

Internet

https://www.mdpi.com/2072-6694/12/10/2859

Similar Items